Mark E. Schmidt
Impact in
- Biological Psychiatry top 1%
- Tryptophan and brain disorders
- Psychiatry and Mental health top 0.5%
- Dementia and Cognitive Impairment Research
Papers in
-
- Dementia and Cognitive Impairment Research 28
-
- Medical Imaging Techniques and Applications 22
- Co-authors
- William J. Jagust (5 shared papers)Peter de Boer (8 shared papers)Koen Van Laere (19 shared papers)Pascal A. Sienaert (3 shared papers)Elske Vrieze (3 shared papers)Diego Pizzagalli (2 shared papers)Koen Demyttenaere (3 shared papers)Titia Hompes (3 shared papers)
- Journals
- Alzheimer s & Dementia (24 papers)Journal of Nuclear Medicine (11 papers)European Journal of Nuclear Medicine and Molecular Imaging (7 papers)European Neuropsychopharmacology (6 papers)Neuropsychopharmacology (6 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Mark E. Schmidt
141 papers receiving 6.0k citations
Mark E. Schmidt's Hit Papers
Peers
Comparison fields: 5 of 164
- Biological Psychiatry 306
- Psychiatry and Mental health 1.7k
- Neurology 503
- Behavioral Neuroscience 184
- Cellular and Molecular Neuroscience 986
Countries citing papers authored by Mark E. Schmidt
This map shows the geographic impact of Mark E. Schmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Schmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Schmidt more than expected).
Fields of papers citing papers by Mark E. Schmidt
This network shows the impact of papers produced by Mark E. Schmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Schmidt. The network helps show where Mark E. Schmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Schmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 149 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | The Alzheimer's Disease Neuroimaging Initiative: A review of papers published since its inception Hit paper breakdown → | 2013 | 801 |
| 2 | 2010 | 476 | |
| 3 | 2011 | 415 | |
| 4 | 2012 | 352 | |
| 5 | 2014 | 238 | |
| 6 | 2000 | 229 | |
| 7 | Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688. | 2007 | 149 |
| 8 | A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials Hit paper breakdown → | 2021 | 149 |
| 9 | 2015 | 135 | |
| 10 | 1992 | 128 | |
| 11 | 2013 | 121 | |
| 12 | 2014 | 106 | |
| 13 | 2018 | 90 | |
| 14 | 1996 | 85 | |
| 15 | 2016 | 82 | |
| 16 | 2018 | 78 | |
| 17 | 2020 | 75 | |
| 18 | 2005 | 73 | |
| 19 | 1989 | 73 | |
| 20 | 2013 | 73 |
About Mark E. Schmidt
Mark E. Schmidt is a scholar working on Psychiatry and Mental health, Radiology, Nuclear Medicine and Imaging, Pharmacology, Physiology and Cellular and Molecular Neuroscience, having authored 149 papers that have together received 6.2k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (28 papers), Medical Imaging Techniques and Applications (22 papers), Alzheimer's disease research and treatments (20 papers), Treatment of Major Depression (13 papers), Neuroscience and Neuropharmacology Research (12 papers), Computational Drug Discovery Methods (11 papers), Tryptophan and brain disorders (8 papers) and Functional Brain Connectivity Studies (8 papers). The work is most often cited by research in Biological Psychiatry (306 citations), Psychiatry and Mental health (1.7k citations), Neurology (503 citations), Behavioral Neuroscience (184 citations) and Cellular and Molecular Neuroscience (986 citations). Mark E. Schmidt has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include William J. Jagust, Peter de Boer, Koen Van Laere, Pascal A. Sienaert, Elske Vrieze, Diego Pizzagalli, Koen Demyttenaere, Titia Hompes, Stephan J. Claes and Guy M Bormans. Their work appears in journals such as Alzheimer s & Dementia, Journal of Nuclear Medicine, European Journal of Nuclear Medicine and Molecular Imaging, European Neuropsychopharmacology and Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.